SeaStar Medical Holding Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ICU research report →
Companywww.seastarmedical.com
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome.
- CEO
- Eric Schlorff
- IPO
- 2021
- Employees
- 19
- HQ
- Denver, CO, US
Price Chart
Valuation
- Market Cap
- $11.27M
- P/E
- -13.07
- P/S
- 7.85
- P/B
- 21.27
- EV/EBITDA
- -0.19
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 93.11%
- Op Margin
- -832.45%
- Net Margin
- -828.62%
- ROE
- -146.29%
- ROIC
- -156.34%
Growth & Income
- Revenue
- $1.23M · 814.07%
- Net Income
- $-12,150,000 · 51.07%
- EPS
- $-5.86 · 91.16%
- Op Income
- $-12,175,000
- FCF YoY
- 15.04%
Performance & Tape
- 52W High
- $13.40
- 52W Low
- $2.07
- 50D MA
- $3.71
- 200D MA
- $4.61
- Beta
- -1.02
- Avg Volume
- 139.04K
Get TickerSpark's AI analysis on ICU
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 6, 26 | Van Heel Kenneth | other | 3,000 |
| Feb 6, 26 | Neuman John | other | 3,000 |
| Feb 6, 26 | Vincent Bernadette N | other | 3,000 |
| Feb 6, 26 | Baird Jennifer A | other | 3,000 |
| Feb 6, 26 | Towne Bradford K | other | 7,500 |
| Feb 6, 26 | Chung Kevin | other | 15,000 |
| Feb 6, 26 | Schlorff Eric | other | 30,000 |
| Dec 19, 25 | Baird Jennifer A | buy | 4,200 |
| Dec 9, 25 | Messinger Michael | buy | 14,500 |
| Nov 14, 25 | Messinger Michael | other | 0 |
Our ICU Coverage
We haven't published any research on ICU yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ICU Report →